| Literature DB >> 34887451 |
Vicky Makker1,2, Helen MacKay3, Isabelle Ray-Coquard4, Douglas A Levine5,6, Shannon N Westin7, Daisuke Aoki8, Ana Oaknin9.
Abstract
Although endometrial cancer management remains challenging, a deeper understanding of the genetic diversity as well as the drivers of the various pathogenic states of this disease has led to development of divergent management approaches in an effort to improve therapeutic precision in this complex malignancy. This comprehensive review provides an update on the epidemiology, pathophysiology, diagnosis and molecular classification, recent advancements in disease management, as well as important patient quality-of-life considerations and emerging developments in the rapidly evolving therapeutic landscape of endometrial cancers.Entities:
Mesh:
Year: 2021 PMID: 34887451 PMCID: PMC9421940 DOI: 10.1038/s41572-021-00324-8
Source DB: PubMed Journal: Nat Rev Dis Primers ISSN: 2056-676X Impact factor: 65.038